Jesper Mosolff Mathiesen

Jesper Mosolff Mathiesen

Auto-generated profile, based on publicly available information

Jesper Mosolff Mathiesen

Department of Drug Design and Pharmacology University of Copenhagen Copenhagen Denmark

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 July 2011 in Nature
Verified
Journal Article
Open access
PDF file
SRSøren G. F. Rasmussen
Søren G. F. Rasmussen
BDBrian T. DeVree
Brian T. DeVree
YZYaozhong Zou
Yaozhong Zou
AKAndrew C. Kruse
Andrew C. Kruse
KCKa Young Chung
Ka Young Chung
BKBrian K. Kobilka
Brian K. Kobilka
G protein-coupled receptors (GPCRs) are responsible for the majority of cellular responses to hormones and neurotransmitters as well as the senses of sight, olfaction and taste. The paradigm of GPCR signalling is the activation of a heterotrimeric GTP binding protein (G protein) by an agonist-occupied receptor. The β2 adrenergic receptor (β2AR) activation of Gs, the stimulatory G protein for adenylyl cyclase, has long been a model system for GPCR signalling. Here we present the crystal structure of the active state ternary complex composed of agonist-occupied monomeric β2AR and nucleotide-free Gs heterotrimer. The principal interactions between the β2AR and Gs involve the amino- and carboxy-terminal α-helices of Gs, with conformational changes propagating to the nucleotide-binding pocket. The largest conformational changes in the β2AR include a 14 Å outward movement at the cytoplasmic end of transmembrane segment 6 (TM6) and an α-helical extension of the cytoplasmic end of TM5. The most surprising observation is a major displacement of the α-helical domain of Gαs relative to the Ras-like GTPase domain. This crystal structure represents the first high-resolution view of transmembrane signalling by a GPCR.

21 March 2012 in Nature
Verified
Journal Article
Open access
PDF file
AMAashish Manglik
Aashish Manglik
AKAndrew C. Kruse
Andrew C. Kruse
TKTong Sun Kobilka
Tong Sun Kobilka
FTFoon Sun Thian
Foon Sun Thian
JMJesper M. Mathiesen
Jesper M. Mathiesen
SGSébastien Granier
Sébastien Granier
Opium is one of the world’s oldest drugs, and its derivatives morphine and codeine are among the most used clinical drugs to relieve severe pain. These prototypical opioids produce analgesia as well as many undesirable side effects (sedation, apnoea and dependence) by binding to and activating the G-protein-coupled µ-opioid receptor (µ-OR) in the central nervous system. Here we describe the 2.8 Å crystal structure of the mouse µ-OR in complex with an irreversible morphinan antagonist. Compared to the buried binding pocket observed in most G-protein-coupled receptors published so far, the morphinan ligand binds deeply within a large solvent-exposed pocket. Of particular interest, the µ-OR crystallizes as a two-fold symmetrical dimer through a four-helix bundle motif formed by transmembrane segments 5 and 6. These high-resolution insights into opioid receptor structure will enable the application of structure-based approaches to develop better drugs for the management of pain and addiction.

23 January 2019 in Nature
Verified
Journal Article
Closed access
PDF file
AKAntoine Koehl
Antoine Koehl
HHHongli Hu
Hongli Hu
DFDan Feng
Dan Feng
BSBingfa Sun
Bingfa Sun
YZYan Zhou
Yan Zhou
BKBrian K. Kobilka
Brian K. Kobilka

1 May 2019 in Cell
Verified
Journal Article
Closed access
XLXiangyu Liu
Xiangyu Liu
XXXinyu Xu
Xinyu Xu
DHDaniel Hilger
Daniel Hilger
PAPhilipp Aschauer
Philipp Aschauer
JTJohanna K.S. Tiemann
Johanna K.S. Tiemann
BKBrian K. Kobilka
Brian K. Kobilka

31 July 2020 in Science
Verified
Journal Article
Closed access
DHDaniel Hilger
Daniel Hilger
KKKaavya Krishna Kumar
Kaavya Krishna Kumar
HHHongli Hu
Hongli Hu
MPMie Fabricius Pedersen
Mie Fabricius Pedersen
EOEvan S. O’brien
Evan S. O’brien
BKBrian K. Kobilka
Brian K. Kobilka
Revealing family differences: In response to low blood glucose concentrations, both the glucagon receptor (GCGR)—a family B G protein–coupled receptor (GPCR)—and the β 2 adrenergic receptor (β 2 AR)—a family A GPCR—are activated and act through the cyclic adenosine monophosphate signaling pathway to increase glucose production. The kinetics of the response is different for the two receptors. Based on structural and spectroscopic data, Hilger et al. show that the conformation of transmembrane helix 6 in the activated state is a key differentiator (see the Perspective by Lebon). In β 2 AR, the helix moves toward its active conformation when an agonist binds, but in GCGR, both agonist and G protein binding are required. This likely explains why activation of its partner G protein is slower for GCGR than for β 2 AR. Science , this issue p. eaba3373 ; see also p. 507

1 March 2003 in British Journal of Pharmacology
Verified
Journal Article
Closed access
PDF file
JMJesper Mosolff Mathiesen
Jesper Mosolff Mathiesen
NSNannette Svendsen
Nannette Svendsen
HBHans Bräuner-Osborne
Hans Bräuner-Osborne
CTChristian Thomsen
Christian Thomsen
MRM Teresa Ramirez
M Teresa Ramirez